GLP-1R injectable drugs are effective in treating obesity, but their success points to a gap in the market: oral alternatives ...
Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...
Qatar Foundation member Sidra Medicine has conducted the industry-sponsored ‘sunRIZE’ trial for paediatric congenital ...
Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first participant ...
Minghui has reported positive topline outcomes from the Phase III trial of MH004 for treating mild to moderate atopic ...
Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of TRP-8803, for ...
The Phase I trial of the combination therapy saw a an approximate 66% rate of near-complete remission in its cohort of breast ...
Gilead Sciences has announced the outcomes from the Phase III PURPOSE 2 trial evaluating lenacapavir for HIV prevention.
As more companies are investigating radiopharmaceuticals, the complexities and red tape faced by sponsors are becoming more ...
Professor Rebecca Fitzgerald demonstrates the capsule sponge. Credit: StillVision. A pivotal investigator-led clinical trial for a new ‘pill-on-a-thread’ innovation for oesophageal cancer screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback